Our data showed that only a high dose of AICAR treatment (3 mM) reduced MUC1-CT protein expression (p < 0.05) (fig. S4B), indicating that AICAR treatment can also block MUC1-CT expression in MUC1 highly abundant lung cancer cell lines. The gene discussed is MUC1; the disease is lung cancer.